Skip to main content

Table 1 Clinical characteristics of the study groups at visit 0 and visit 1

From: Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study

 

EH (n = 43) visit 0

EH (n = 43) visit 1

T2DM (n = 27) visit 0

T2DM (n = 27) visit 1

Age (years)

51.7 ± 8.0

-

60.0 ± 10.5*

-

Men (n,%)

32 (74 %)

-

14 (52 %)

-

Smokers (n,%)

9 (21 %)

-

5 (19 %)

-

BMI (Kg/m2)

26.6 (24.6-31.1)

28.4 (25.1-30.1)

30.0 (27.9-36.1)*

29.2 (27.2-35.1)

Brachial systolic BP (mmHg)

142.7 ± 9.9

144.5 ± 17.9

139.8 ± 14.5

141.2 ± 10.7

Brachial diastolic BP (mmHg)

86.1 ± 8.1

86.9 ± 11.8

78.7 ± 8.8*

73.1 ± 9.4

Brachial PP (mmHg)

56.6 ± 8.1

57.6 ± 11.1

61.1 ± 16.6

68.2 ± 13.7

Mean BP (mmHg)

105.7 ± 7.9

107.1 ± 11.5

100.6 ± 7.9*

96.6 ± 7.6

Aortic systolic BP (mmHg)

131.5 ± 11.8

132.4 ± 13.0

128.6 ± 17.2

126.9 ± 10.1

Aortic PP (mmHg)

47.2 ± 13.7

45.2 ± 8.6

51.4 ± 16.4

52.9 ± 13.5

Heart rate (bpm)

65.8 ± 10.5

71.1 ± 10.4#

68.5 ± 12.6

68.6 ± 11.8

Fasting plasma glucose (mg/dl)

90 (86–95)

90 (86–96)

140 (119–183)*

114 (107–132)#

Hb1Ac (%)

5.2 (5.0-5.7)

5.4 (5.0-6.4)

6.9 (6.4-7.4)*

6.4 (6.1-7.1) #

Total cholesterol (mg/dl)

209 ± 34

206 ± 39

227 ± 53

183 ± 38#

LDL-cholesterol (mg/dl)

137 ± 36

127 ± 36

131 ± 57

107 ± 31

HDL-cholesterol (mg/dl)

50 ± 14

53 ± 12

50 ± 17

52 ± 13

Triglycerides (mg/dl)

104 (71–174)

108 (73–162)

164 (102–247)

131 (91–159)

Serum creatinine (mg/dl)

0.90 ± 0.17

0.91 ± 0.18

0.86 ± 0.21

0.85 ± 0.19

eGFR (ml/min/1.73 m2)

91.1 ± 13.7

86.9 ± 13.4

86.3 ± 15.1

84.4 ± 14.2

UACR (mg/g)

2.0 (0–5.9)

9.3 (5.7-18.4) #

6.6 (1.6-15.5)*

10.7 (3.8-44.8) #

Nitrotyrosine (μmol/l )

9.8 ± 1.4

12.2 ± 3.2 #

13.1 ± 2.5*

11.9 ± 3.4

  1. *p < 0.05 vs EH group
  2. #p < 0.05 vs Visit 0